Literature DB >> 8780570

Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis.

R Negrini1, A Savio, C Poiesi, B J Appelmelk, F Buffoli, A Paterlini, P Cesari, M Graffeo, D Vaira, G Franzin.   

Abstract

BACKGROUND & AIMS: The majority of patients with Helicobacter pylori infection have autoantibodies cross-reacting with gastric antigens. In this study, the relation between autoantibody status, histopathology of body mucosa, and antigenic profile of H. pylori was investigated.
METHODS: One hundred patients were examined for H. pylori infection, body gastritis, and gastric autoantibodies. Balb/c mice were analyzed for serum autoantibodies after immunization with H. pylori from patients with and without atrophic gastritis.
RESULTS: Immunoglobulin G autoantibodies were detected in 57 of the 87 infected patients (65.5%) but in none of the 13 patients without infection and gastritis. The autoreaction involved mainly the luminal surface of glandular cells and secretory canaliculi of parietal cells. The autoantibody status correlated with the presence and degree of inflammation and atrophy of the glands. H. pylori from patients with atrophic gastritis showed a higher capacity to induce autoantibodies than H. pylori from patients with a minimal superficial gastritis. Monoclonal antibodies showed differences in the bacterial expression of cross-reacting determinants.
CONCLUSIONS: H. pylori-mediated autoimmunity is involved in the pathogenesis of chronic atrophic gastritis. The grade of antigenic mimicry of the infecting H. pylori strain plays a role in the progression of chronic gastritis to atrophy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780570     DOI: 10.1053/gast.1996.v111.pm8780570

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  79 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  Extradigestive manifestations of Helicobacter pylori infection: fact and fiction.

Authors:  G Realdi; M P Dore; L Fastame
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

3.  Helicobacter pylori infection.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

4.  Relationship of anti-Lewis x and anti-Lewis y antibodies in serum samples from gastric cancer and chronic gastritis patients to Helicobacter pylori-mediated autoimmunity.

Authors:  M A Heneghan; C F McCarthy; D Janulaityte; A P Moran
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 5.  Current views of the relationship between Helicobacter pylori and Henoch-Schonlein purpura in children.

Authors:  Li-Jing Xiong; Meng Mao
Journal:  World J Clin Pediatr       Date:  2016-02-08

6.  Diphenyleneiodonium inhibits the activation of mitogen-activated protein kinases and the expression of monocyte chemoattractant protein-1 in Helicobacter pylori-infected gastric epithelial AGS cells.

Authors:  Soon Ok Cho; Joo Weon Lim; Kyung Hwan Kim; Hyeyoung Kim
Journal:  Inflamm Res       Date:  2010-12-23       Impact factor: 4.575

Review 7.  Synchronous and metachronous occurrence of gastric adenocarcinoma and gastric lymphoma: A review of the literature.

Authors:  Erhan Hamaloglu; Serdar Topaloglu; Arif Ozdemir; Ahmet Ozenc
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

8.  Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis?

Authors:  Paolo A Tomasi; Maria P Dore; Giuseppe Fanciulli; Franca Sanciu; Giuseppe Realdi; Giuseppe Delitala
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

9.  Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon.

Authors:  A Gasbarrini; I Massari; M Serricchio; P Tondi; A De Luca; F Franceschi; V Ojetti; A Dal Lago; R Flore; A Santoliquido; G Gasbarrini; P Pola
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

10.  Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review.

Authors:  Keiko Ando; Takashi Shimamoto; Tetsuzo Tauchi; Yoshikazu Ito; Yuzuru Kuriyama; Akihiko Gotoh; Keisuke Miyazawa; Yukihiko Kimura; Takashi Kawai; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.